Why the study?
Does a difluorostatone-containing peptide inhibit human renin more potently than statine- or statone-containing peptides in vitro?
Population
Human renin (in vitro biochemical assay)
Comparison
BOC-Phe-Phe-difluorostatone-Leu-Phe-NH2 vs Analogous statine- and statone-containing peptides
Design
Preclinical
Authors
Loading...
May inform renin inhibitor design; leaves open in vivo efficacy and clinical translation.
Does a difluorostatone-containing peptide inhibit human renin more potently than statine- or statone-containing peptides in vitro?
A novel difluorostatone-containing peptide demonstrates significantly greater potency as a human renin inhibitor compared to traditional statine-based peptides in vitro.
Fearon et al. (1987) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: